Test Price
2,800 AED✅ Home Collection Available
MED23 Gene Autosomal Recessive Intellectual Disability Type 18 (MRT18) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MED23 للإعاقة الذهنية الصبغية الجسدية المتنحية نوع 18 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي: فحص جيني عالي الدقة لتشخيص طفرة جين MED23 باستخدام تقنية التسلسل الجيني من الجيل التالي (NGS)، يوفر تشخيصًا دقيقًا للإعاقة الذهنية الوراثية المتنحية من النوع 18، مع ضمان الامتثال الكامل لمعايير هيئة الصحة بدبي والقوانين الاتحادية.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM daily).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed Consultant Neurologist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview
The MED23 gene test analyzes the entire coding region using Next-Generation Sequencing (NGS) to detect pathogenic variants causing autosomal recessive intellectual disability type 18 (MRT18). This highly sensitive assay is essential for confirming clinical diagnosis, carrier screening, and guiding family planning decisions. يُعد هذا التحليل أساسيًا لتأكيد التشخيص السريري وتقديم المشورة الوراثية للعائلات المعرضة للخطر.
| Feature | Our Test (AMCA Lab – DHA Licensed) | Closest Alternative (Overseas Referral Lab) |
|---|---|---|
| Methodology | Full-gene NGS (Illumina® platform) with deletion/duplication analysis | Targeted Sanger sequencing only (limited to known hotspots) |
| Turnaround Time | 3–4 Weeks (fast-track available) | 6–8 Weeks |
| UAE Regulatory Compliance | DHA/MOHAP Licensed Facility #9834453; ISO 9001:2015; Federal Decree-Law No. 41 of 2024 Art. 87 | No UAE license; samples shipped abroad with uncertain data privacy |
| Genetic Counseling | Included pre- and post-test session with pedigree chart | Not provided |
Physician Insight & Safety Protocol
“As a Consultant Neurologist (DHA License: 61713011) with extensive experience in neurodevelopmental disorders, I emphasize that a positive MED23 result must be correlated with detailed clinical phenotyping and neurodevelopmental assessments. This test provides molecular confirmation, but the full picture of your child’s health requires a multidisciplinary approach. Please remember that genetic information empowers, but does not define, a person’s potential.” – Dr. Prabhakar Reddy
Critical Safety Notice
- Medication Warning: Do not discontinue any prescribed anti‑epileptic, psychotropic, or other regular medication without consulting your treating physician.
- Exclusion Criteria: This test is not intended for prenatal diagnosis of MRT18 without prior genetic counseling. Home collection is contraindicated if the patient is hemodynamically unstable or has acute neurological deterioration.
- Emergency Red Flags: Seek immediate emergency care if the patient develops new‑onset seizures, loss of consciousness, or sudden worsening of intellectual/behavioral symptoms.
- Pediatric Consent: In compliance with UAE CDS Law 2026, testing of minors requires written informed consent from both parents or legal guardians.
Patient FAQ & Clinical Guidance
1. What does a positive MED23 mutation test mean for my child’s future?
A positive result confirms a diagnosis of autosomal recessive intellectual disability type 18, which typically presents with moderate to severe developmental delay and absence of speech. النتيجة الإيجابية تؤكد التشخيص وتساعد في التخطيط للتدخل المبكر والرعاية المتخصصة. However, clinical course varies; early intervention with speech, physiotherapy, and specialized education can significantly improve quality of life.
2. How accurate is this NGS compared to older genetic methods?
Our NGS assay achieves >99.9% analytical sensitivity and specificity for single nucleotide variants and small indels in the MED23 gene. تقنيات التسلسل المتقدمة تفوق دقة الطرق التقليدية وتكشف الطفرات النادرة التي قد تفوتها الاختبارات القديمة. It also detects copy number variations missed by Sanger sequencing, providing a comprehensive molecular result.
3. Is home sample collection reliable for DNA testing?
Yes, when performed by our DHA‑certified phlebotomy team using ISO cold‑chain transport, DNA integrity is fully preserved from the FTA card, whole blood, or extracted DNA. خدمة سحب الدم المنزلي المعتمدة تضمن عينة عالية الجودة خالية من التلوث وتلتزم بالمعايير الدولية. The process is identical to hospital draw and offers the convenience of your home.
Regulatory References: Federal Decree‑Law No. 41 of 2024 on Genetic Testing (Art. 87); UAE CDS Law 2026 (Consent for Minors); UAE PDPL (Data Privacy).
Facility License: MOHAP/DHA #9834453 | ISO 9001:2015 Cert: INT/EGQ/2509DA/3139
Emergency / Support: WhatsApp +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians